Research Expert: Sarah Overall
  • Published: Mar 2025
  • Pages: 150
  • SKU: IRTNTR74082

  • France Neonatal and Prenatal Devices Market Analysis and Forecast 2024-2028

    The France neonatal and prenatal devices market is projected to grow by USD 498.9 million at a CAGR of 4.5% between 2023 and 2028. This growth is primarily driven by the increasing incidence of preterm births and a rising awareness of fetal screening and monitoring procedures. However, affordability issues remain a significant challenge for many healthcare providers and patients, limiting access to advanced medical technologies in neonatal and prenatal care.

    Neonatal And Prenatal Devices Market in France 2024-2028

    For more details about the industry, get the PDF sample report for free

    Market Segmentation

    By End-User

    • Hospitals
    • Diagnostic Centers
    • Others

    By Type

    • Prenatal and Fetal Equipment
    • Neonatal Equipment

    By Region

    • France

    By End-User Insights

    Hospitals Segment

    The hospitals segment is expected to see significant growth throughout the forecast period. Hospitals, particularly those with neonatal intensive care units (NICUs), remain the primary end-users of neonatal and prenatal medical technologies. Specialized clinical teams in these hospitals focus on managing high-risk infants, extremely preterm babies, and birth-related complications.

    Key devices used in hospital NICUs include:

    • Capillary oxygen saturation monitors
    • Electrocardiogram (ECG) devices
    • Surface temperature monitors
    • Brain activity monitors

    Innovative neonatal therapies and diagnostics continue to emerge, improving health outcomes for premature and high-risk infants. Technologies such as delayed cord clamping, LifeStart, Inspire, and Concord are being integrated into hospital practices to enhance newborn care.

    Hospitals accounted for a market value of USD 983.60 million in 2018 and have demonstrated a steady increase throughout the forecast period.

    Market Dynamics

    Drivers

    Rising Incidence of Preterm Births

    Preterm birth, defined as the delivery of a baby before 37 weeks of gestation, remains a critical health concern in France. Several risk factors contribute to preterm births, including:

    • Short intervals between pregnancies
    • In-vitro fertilization (IVF)
    • Infections in amniotic fluid and the lower genital tract
    • Multiple miscarriages or abortions
    • Multiple pregnancies
    • Chronic conditions such as diabetes and high blood pressure

    Preterm births are categorized into three groups based on gestational age:

    1. Extremely preterm: Less than 28 weeks
    2. Very preterm: 28 to 32 weeks
    3. Moderate-to-late preterm: 32 to 37 weeks

    Premature babies face a higher risk of mortality and long-term health complications, including cerebral palsy, learning disabilities, sensory impairments, developmental delays, and respiratory issues. Neonatal and prenatal devices play a crucial role in monitoring and supporting premature infants, improving overall health outcomes and reducing neonatal mortality rates.

    Trends

    Growing Awareness of Fetal Screening and Monitoring Procedures

    The France neonatal and prenatal devices market is witnessing an increase in demand for fetal screening and monitoring technologies due to rising concerns about neonatal mortality and genetic disorders. Genetic disorders, including Down syndrome and other chromosomal abnormalities, contribute significantly to stillbirths and infant mortality.

    Several French authorities and private organizations are actively promoting prenatal screening initiatives. Expecting mothers are increasingly adopting non-invasive prenatal testing (NIPT) and other screening methods to detect potential genetic defects early. This growing awareness and adoption of advanced screening methods are fueling the market expansion.

    Challenges

    Affordability Issues

    Despite technological advancements, high costs remain a major barrier in the France neonatal and prenatal devices market. The cost of neonatal intensive care unit (NICU) treatments exceeds USD 125 per patient per day, making access to these critical healthcare services difficult for many middle-class families.

    The financial burden on healthcare institutions and families limits the widespread adoption of neonatal and prenatal devices in hospitals and diagnostic centers. The high initial investment and maintenance costs of these devices further impede market growth.

    Market Research Overview

    The neonatal and prenatal devices market is experiencing significant growth, driven by the increasing demand for fetal monitoring systems and neonatal incubators in healthcare facilities. Technological advancements in phototherapy equipment, infant warmers, and neonatal ventilators have enhanced the ability of healthcare providers to manage preterm births effectively. The rising adoption of prenatal ultrasound devices and fetal Doppler monitors supports early detection of fetal health complications, contributing to improved maternal and infant care. Additionally, neonatal resuscitation units and pulse oximetry for neonates are becoming essential in premature infant care, ensuring real-time monitoring of critical health parameters. As the focus on maternal health monitoring intensifies, the demand for NICU equipment continues to expand, reinforcing the need for specialized medical technologies in neonatal and prenatal care.

    Get more details by ordering the complete report

    Key Players

    The France neonatal and prenatal devices market includes several prominent companies engaged in product innovation, mergers and acquisitions, strategic alliances, and geographical expansion. The major key players operating in the market are:

    • Atom Medical Corp.
    • Baxter International Inc.
    • Becton Dickinson and Co.
    • Cardinal Health Inc.
    • Dragerwerk AG and Co. KGaA
    • Fisher and Paykel Healthcare Corp. Ltd.
    • FUJIFILM Corp.
    • General Electric Co.
    • Getinge AB
    • Inspiration Healthcare Group Plc.
    • Koninklijke Philips N.V.
    • Masimo Corp.
    • Medtronic Plc
    • Natus Medical Inc.
    • Neoventa Medical AB
    • Nihon Kohden Corp.
    • OSI Systems Inc.
    • Smiths Group Plc
    • Utah Medical Products Inc.
    • Vyaire Medical Inc.

    Research Analysis Overview

    Innovations in non-invasive prenatal testing and neonatal apnea monitors are transforming the landscape of portable prenatal devices, providing greater accessibility and accuracy in advanced neonatal care. The development of prenatal diagnostics technology has led to improved screening techniques, aiding in the early detection of genetic abnormalities and fetal health risks. The integration of neonatal and prenatal market trends into healthcare strategies reflects the growing emphasis on enhancing neonatal survival rates and maternal well-being. The introduction of cutting-edge solutions in prenatal diagnostics technology ensures better outcomes for newborns and expectant mothers. With continuous advancements in neonatal and prenatal care, medical institutions are increasingly investing in state-of-the-art equipment to meet the evolving needs of healthcare professionals and patients.

     

     

    Read News Read Less
    Interested in this report?
    Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.